Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy

American Journal of Reproductive Immunology

Volumn 41, Issue 1, 1999, Pages 41-51

  Hammer, Astrid ^a   Blaschitz, Astrid ^a   Daxböck, Christine ^a   Walcher, Wolfgang ^a   Dohr, Gottfried ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Apoptosis; Fas Fas ligand; Human placenta; Immunohistochemistry; Reproductive immunology; Trophoblast

Indexed keywords

CD45 ANTIGEN; FAS ANTIGEN; FAS LIGAND;

CONFERENCE PAPER; CYTOTROPHOBLAST; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MATERNAL BLOOD; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROPHOBLAST; UTERUS; WESTERN BLOTTING;

EID: 0033015629     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1999.tb00074.x     Document Type: Conference Paper

References (41)

1. Trauth BC, Klas C, Peters AMJ, Matzuku S, Möller P, Falk W, Debatin KM, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245:301-305.
2. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (antiFas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169:1747-1756.
3. Suda T, Nagata S: Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994; 179:873-879.
4. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 1994; 76:959-962.
5. Suda T, Takahashi T, Goldstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a member of the tumor necrosis factor family. Cell 1993; 75:1169-1178.
6. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin GR, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995; 181:71-77.
7. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC: A role for CD95 ligand in preventing graft rejection. Nature 1995; 377:630-632.
8. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligand-induced apoptosis is a mechanism of immune privilege. Science 1995; 270:1189-1192.
9. Korbutt GS, Elliott JF, Rajotte RV: Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunsuppression. Diabetes 1997; 46:317-322.
10. Lau HT, Yu M, Fontana A, Stoeckert CJ: Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996; 273:109-112.
11. Hunt JS, Vassmer D, Ferguson TA, Miller L: Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol 1997; 158:4122-4128.
12. Xerri L, Devilard E, Hassoun J, Mawas C, Birg F: Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues. J Clin Pathol Mol Pathol 1997; 50:87-91.
13. Bamberger AM, Schulte HM, Thuneke I, Erdmann I, Bamberger CM, Asa S: Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 1997; 82:3173-3175.
14. Hartmann M, Blaschitz A, Hammer A, Haidacher S, Mahnert W, Walcher W, Dohr G: Immunohistochemical examination of trophoblast populations in human first trimester and term placentae and of first trimester spiral arteries with the monoclonal antibody GZ 112. Placenta 1997; 18:481-489.
15. Aboagye-Mathiesen G, Laugesen J, Zdrakovic M, Ebbesen P: Isolation and characterization of human placental trophoblast subpopulations from first-trimester chorionic villi. Clin Diagn Lab Immunol 1996; 3:14-22.
16. Hammer A, Hutter H, Blaschitz A, Mahnert W, Hartmann M, Uchanska-Ziegler B, Ziegler A, Dohr G: Amnion epithelial cells, in contrast to trophoblast cells, express all classical HLA class I molecules together with HLA-G. Am J Reprod Immunol 1997; 37:161-171.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
18. Loke YW, King A: Human Implantation: Cell Biology and Immunology. Cambridge UK, Cambridge University Press, 1995.
19. Huppertz B, Frank HG, Kingdom JCP, Reister F, Kaufmann P: Villous cytotrophoblast repulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol 1998; 110:495-508.
20. Benirschke K, Kaufmann P: Pathology of the Human Placenta, 3rd ed. New York, Springer-Verlag, 1995, pp. 28 and 231.
21. Uckan D, Steele A, Cherry, Wang BY, Chamizo W, Koutsonikolis A, Gilbert-Barness E, Good RA: Trophoblasts express Fas ligand: A proposed mechanism for immune privilege in placenta and maternal invasion. Mol Hum Reprod 1997;3:655-662.
22. Hutter H, Hammer A, Blaschitz A, Hartmann M, Ebbesen P, Dohr G, Ziegler A, Uchanska-Ziegler B: Expression of HLA class I molecules in human first trimester and term placenta trophoblast. Cell Tissue Res 1996; 286:437-444.
23. King A, Boocock C, Sharkey AM, Gardner L, Beretta A, Siccardi AG, Loke YW: Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J Immunol 1996: 156:2068-2076.
24. Hammer A, Hutter H, Dohr G: HLA class I expression on the materno - fetal interface. Am J Reprod Immunol 1997; 8:150-157.
25. King A, Birkby C, Loke YW: Early human decidual cells exhibit NK activity against K 562 cell line but not against first trimester trophoblast. Cell Immunol 1989; 118:227-244.
26. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D: Granulated lymphocytes in human endometrium: Histochemical and immunohistochemical studies. Human Reprod 1991; 6:791-798.
27. Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE: Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175:305-308.
28. Saito S, Nishikawa K, Morii T, Narita N, Enomoto M, Ichijo M: Expression of activation antigens CD69, HLA-DR, interleukin-2 receptor-alpha (IL-2R alpha) and IL-2R beta on T cells of human decidua at an early stage of pregnancy. Immunology 1992; 75:710-712.
29. Borrego F, Pena J, Solana R: Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases. Eur J Immunol 1993; 23:1039-1043.
30. Santis AG, Lopez-Cabrera M, Hamann J, Strauss M, Sanchez-Madrid F: Structure of the gene coding for the human early lymphocyte activation antigen CD69: a C-type lectin receptor evolutionarily related with the gene families of natural killer cell-specific receptors. Eur J Immunol 1994; 24:1692-1697.
31. Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B: T cell awareness of paternal alloantigens during pregnancy. Science 1995; 270:630-633.
32. Beer AE, Billingham RE: Host responses to intra-uterine, tissue, cellular and fetal allografts. J Reprod Fertil Suppl 1974; 21:59-88.
33. Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA: CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 1997; 99:396-402.
34. Takahashi T, Tanaka M, Brannan C, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliverative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76:969-976.
35. Hahne M, Peitsch MD, Irmler M, Schroter M, Lowin B, Rousseau M, Bron C, Renno T, French L, Tschopp J: Characterization of the non-functional Fas ligand of gld mice. Int Immunol 1995; 7:1381-1386.
36. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N: Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 1994; 84:1201-1208.
37. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ: Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med 1996; 184:429-440.
38. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N: Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992; 149:3753-3758.
39. Eischen CM, Schilling JD, Lynch DH, Krammer PH, Leibson PJ: Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J Immunol 1996; 156:2693-2699.
40. Saito S, Nishikawa K, Morii T, Narita N, Enomoto M, Ito A, Ichijo M: A study of CD45RO, CD45RA and CD29 antigen expression on human decidual T cells in an early stage of pregnancy. Immunol Lett 1994; 40:193-197.
41. Klas C, Debatin KM, Jonker RR, Krammer PH: Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 1993; 5:625-630.